LB Pharmaceuticals Inc (LBRX) PT Raised to $40 at Stifel After Q4 Results
Tweet Send to a Friend
Stifel analyst Paul Matteis raised the price target on LB Pharmaceuticals Inc (NASDAQ: LBRX) to $40.00 (from $35.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
